In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants.
Anyone suffering dry skin, eczema, or insect bites will know the unpleasant effects of itchy skin.
Golden State Dermatology (GSD) is pleased to announce a new partnership with the dermatology practice of Emil Tanghetti, MD located in Sacramento, CA. The new partnership expands GSD's network to 28 practices across the San Francisco Bay and California's Central Valley and Sacramento Valley.
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped
With the holidays upon us, kitchen accidents can become more common as we cook meals for large gatherings of friends and family. In preparation for the holiday season, a board-certified dermatologist from the American Academy of Dermatology (AAD) is sharing tips on how to treat minor burns and cuts and apply proper wound care.
A just-published study by Dr. John Pezzuto of the Western New England University College of Pharmacy and Health Sciences found that consuming grapes protected against ultraviolet damage to the skin.
With a new $3 million-plus grant from the National Institutes of Health (NIH), Case Western Reserve University researchers are examining the next level of treatment for Candida auris (C.auris), a multidrug-resistant yeast that causes serious infection and, in some cases, death.
ROSEMONT, Ill. (November 30, 2022) — Board-certified dermatologist John Browning MD, FAAD, FAAP, adjunct associate professor of pediatrics and dermatology at UT Health in San Antonio, was named an American Academy of Dermatology Patient Care Hero for his expertise in laser treatments that helped relieve his pediatric patient's pain and improve his quality of life.
After healing, minor facial scars have little or no effect on ratings of attractiveness – while some scars are even linked to more favorable ratings, suggests a survey study in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Accure Acne, Inc. (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today it has received FDA clearance for its Accure Laser™ System to treat mild to severe inflammatory acne vulgaris.
Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. As your body’s largest organ, it’s important to take good care of your skin. In recognition of National Healthy Skin Month in November, a board-certified dermatologist from the American Academy of Dermatology offers tips to help treat acne.
Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.
After sun exposure, people with systemic lupus erythematosus (SLE) frequently develop skin rashes, which often are accompanied by a flare of their overall disease. This connection between ultraviolet (UV) light and disease flares in lupus is well known, but the way in which UV exposure actually triggers the disease has been poorly understood.
Christopher Bengson MD, MHS, FAAD, a board-certified dermatologist for the Indian Health Service in Phoenix, Ariz., and a Commander in the U.S. Public Health Service, was named an American Academy of Dermatology Patient Care Hero for making a life-saving recommendation that prevented a heart attack in a psoriasis patient.
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
